Trial Profile
Glucocorticoid-Induced Osteoporosis Treated with Bisphosphonate and Denosumab
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Dec 2019
Price :
$35
*
At a glance
- Drugs Denosumab (Primary) ; Bisphosphonates
- Indications Corticosteroid-induced osteoporosis
- Focus Therapeutic Use
- Acronyms GOBID
- 27 Dec 2019 Status changed from active, no longer recruiting to completed.
- 26 Jun 2017 Status changed from recruiting to active, no longer recruiting.
- 10 Jul 2014 New trial record